vancomycin has been researched along with carboplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bratt, GW; Dille, MF; Fausti, SA; Gallun, F; Gordon, JS; Helt, WJ; Konrad-Martin, D; Reavis, KM | 1 |
| Araújo, OR; Barbosa, LC; Carlesse, FAMC; Carreira, LY; Fonseca, FMCD; Lima, APC; Marques, LMA; Pignati, LT; Silva, AMPSD; Silva, DCBD; Sodré, JJM | 1 |
2 other study(ies) available for vancomycin and carboplatin
| Article | Year |
|---|---|
Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carboplatin; Cisplatin; Cross-Sectional Studies; Female; Gentamicins; Hearing Tests; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Risk; Time Factors; Tinnitus; Tobramycin; Vancomycin; Veterans | 2010 |
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.
Topics: Anti-Bacterial Agents; Asparaginase; Busulfan; Cancer Care Facilities; Carboplatin; Case-Control Studies; Cefepime; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Melphalan; Meropenem; Neoplasms; Retrospective Studies; Risk Factors; Vancomycin | 2023 |